期刊文献+

血脂康预处理对大鼠在体心脏急性缺血-再灌注心肌Fas/FasL mRNA表达的影响 被引量:6

Effects of pretreatment with Xuezhikang on the expression of Fas/FasL mRNA in myocardium during rats heart ischemiareperfusion in vivo
下载PDF
导出
摘要 目的探讨血脂康对大鼠在体心脏急性缺血-再灌注心肌Fas/FasLmRNA表达的影响。方法40只雄性SD大鼠随机分成5组,每组8只。假手术组,双蒸水灌胃1周;模型对照组,双蒸水2ml灌胃1周;甲羟戊酸组,甲羟戊酸150mg/kg·d溶于2ml双蒸水灌胃1周;血脂康组,血脂康原粉2.8g/kg·d溶于2ml双蒸水配成悬液灌胃1周;血脂康+甲羟戊酸组,血脂康原粉2.8/kg·d联合甲羟戊酸150mg/kg·d溶于2ml双蒸水灌胃1周。1周后应用0000无创丝线结扎左冠脉前降支,结扎30min后松开恢复冠脉血流复制在体心脏急性缺血-再灌注模型,假手术组仅穿线而不结扎前降支,其他手术步骤相同。再灌注120min后用RT-PCR检测各组心肌Fas和FasLmRNA的表达。结果与假手术组大鼠心肌Fas/FasLmRNA表达相比较,其他4组大鼠心肌Fas/FasLmRNA表达明显升高(P<0.01);与模型对照组比较,血脂康组大鼠心肌Fas/FasLmRNA表达显著减少(P<0.01),血脂康+甲羟戊酸组和甲羟戊酸组大鼠心肌Fas/FasLmRNA表达无差异(P>0.05)。结论血脂康能减少大鼠心脏急性缺血-再灌注心肌Fas/FasLmRNA的表达。 Objective To explore the effects of Xuezhikang on the expression of Fas/FasL in myocardium during rats heart ischemia- repeffusion in vivo.Methods 40 Sprague-Dawley male rats were randomly divided into five groups:the sham group,rats had intragastric administration with 2ml ddH2O once a day;the model control group,rats had intragastric administration with 2ml ddH2O once a day;the mevalonate group,rats had intragastric administration with mevalonate 150mg/kg solved in 2ml ddH20 once a day ;the Xuezhikang group, rats had intragastric administration with Xuezhikang 2.8g/kg solved in 2ml ddH2O once a day;the Xuezhikang+mevalonate group,rats had intragastric administration with Xuezhikang 2.Sg/kg and mevalonate 150mg/kg solved in 2ml ddH2O once a day .One week after preconditioning, the myocardial ischemiarepeffusion model was produced by ligating the left coronary artery 30min and relaxation to repeffuse 120min after one week administration with 0000 silk suture in vivo.In the sham group,sham operations(with 0000 silk suture put beneath the artery but without ligation) were performed. The expression of Fas/FasL mRNA were detected by RT-PCR.Results Compaired with the sham group, the other four groups expressed Fas/FasL mRNA increasly(P〈0.01 ).The expression of Fas/FasL mRNA incresed in Xuezhikang+mevalonate group(P〈0.01 vs. the Xuezhikang group ) .While Fas/Fasl mRNA expressions were not different between contral group,mevalonate group and Xuezikang+mevalonate group (P〉0.05).Conclusion Xuezhikang can reduce the expression of Fas/FasL mRNA in myocardium during rat heart ischemia- repeffusion in vivo.
出处 《江西医药》 CAS 2008年第5期411-414,共4页 Jiangxi Medical Journal
基金 江西省科学自然基金项目(NO.2007GZY1174)
关键词 血脂康 心脏缺血-再灌注 FAS/FASL MRNA Xuezhikang heart ischaemia- reperfusion Fas/FasL mRNA
  • 相关文献

参考文献25

  • 1I Jeremias,C Kupatt,A Martin-Villalba,et al.Involvement of CD95/ Apol/Fas in cell death after myocardial ischemia.Circulation,2000, 102:915 被引量:1
  • 2Peiyee Lee,Masataka Sata,David J. Lefer, et al.Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol,2003,284:H456 被引量:1
  • 3Luis Miguel Blanco-Colio,Jose Luis Martin-Ventura,Begona Munoz-Garcia, et al. 3-Hydroxy-3-Methylglutaryl Coenzyme A reductase inhibitors decrease Fas Ligand expression and cytotoxicity in activated human T lymphocytes.Circulation,2003,108:1506 被引量:1
  • 4Oria de Suarez C,Suarez Rodriguez S,Ponce Hernandez L,et al.Effect of atorvastatin on Fas (CD95/Apo-1) expression in normal or ischemic brain. An Med Interna, 2006, 23(4):156 被引量:1
  • 5Jee BC, Kim SH, Moon SY.The role of nitric oxide on apoptosis in human luteinized granulose cells.Imrnunocytochemical evidence.Gynecologic and Obstetric Investigation, 2003, 56(3):143 被引量:1
  • 6张小茜,周富荣,石济民.高效液相色谱法测血脂康胶囊及红曲中洛伐他汀的含量[J].中华医学信息导报,1997,0(16):23-24. 被引量:2
  • 7L.Gomez,N.Chavanis,L.Argaud,et al.Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion.Am J Physiol Heart Circ Physiol, 2005,289:H2153 被引量:1
  • 8覃数,陈运贞,王志华.大白鼠实验性心肌缺血再灌注模型制备与心电图改变的特点[J].重庆医科大学学报,1998,23(1):8-11. 被引量:53
  • 9Jianguang Chen,Hua Shen,Yoshinobu Nagasawa,et al.Pravastatin inhibits arrhythmias induced by coronary artery ischemia in anesthetized rats. J Pharmacol Sci, 2007, 103:317 被引量:1
  • 10Lefer AM,Scalia R, Lefer DJ.Vascular effects of HMG-CoA reductase inhibitors(statins) unrelated to Cholesterol lowering: new concepts for cardiovascular disease.Cardiovasc Res, 2001,49:281 被引量:1

二级参考文献6

  • 1Mason RP, Walter MF, Jacob RF. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress. Circulation, 2004,109:II34-41. 被引量:1
  • 2Verma S, Rao V, Weisel RD,et al. Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: beneficial effects of statins independent of endothelial cells. J Surg Res, 2004,119:66-71. 被引量:1
  • 3Wang Y, Ahmad N, Kudo M,et al. Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. Am J Physiol Heart Circ Physiol,2004, 287:H1125-1131. 被引量:1
  • 4Tong X, Li H. eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Cancer Lett, 2004,210:63-71. 被引量:1
  • 5Harada M, Aimesempe C, Sato T. Strecture-function analysis of bcl-2 protein; identification of conserved domains important for homodimerization with bcl-2 and heterodimerization with bax. J Biol Chem,1995,270:11962-11969. 被引量:1
  • 6刘付平,姚宏伟,李俊.大鼠心肌缺血再灌注损伤模型的改进[J].安徽医科大学学报,2003,38(3):234-236. 被引量:53

共引文献58

同被引文献17

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部